ERIS LIFESCIENCES
|
ERIS LIFESCIENCES Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Equity - Authorised | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr |
Equity - Issued | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Equity Paid Up | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | ₹10 Cr | ₹5.02 Cr | ₹2.80 Cr | ₹1.90 Cr | ₹3.97 Cr |
Total Reserves | ₹2,831 Cr | ₹2,568 Cr | ₹2,180 Cr | ₹1,893 Cr | ₹1,559 Cr |
Securities Premium | ₹29 Cr | ₹18 Cr | ₹15 Cr | ₹11 Cr | - |
Capital Reserves | ₹8.38 Cr | ₹8.38 Cr | ₹8.38 Cr | ₹8.38 Cr | ₹8.38 Cr |
Profit & Loss Account Balance | ₹2,793 Cr | ₹2,541 Cr | ₹2,156 Cr | ₹1,874 Cr | ₹1,550 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹0.17 Cr | ₹0.17 Cr | ₹0.17 Cr | ₹0.17 Cr | ₹0.17 Cr |
Reserve excluding Revaluation Reserve | ₹2,831 Cr | ₹2,568 Cr | ₹2,180 Cr | ₹1,893 Cr | ₹1,559 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,854 Cr | ₹2,586 Cr | ₹2,196 Cr | ₹1,908 Cr | ₹1,576 Cr |
Minority Interest | ₹417 Cr | ₹636 Cr | ₹25 Cr | ₹-0.11 Cr | ₹0.00 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹1,738 Cr | ₹655 Cr | ₹644 Cr | ₹45 Cr | - |
Non Convertible Debentures | ₹1,250 Cr | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹488 Cr | ₹655 Cr | ₹644 Cr | ₹45 Cr | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹229 Cr | ₹227 Cr | ₹-16 Cr | ₹-197 Cr | ₹-151 Cr |
Deferred Tax Assets | ₹566 Cr | ₹476 Cr | ₹401 Cr | ₹360 Cr | ₹303 Cr |
Deferred Tax Liability | ₹795 Cr | ₹704 Cr | ₹384 Cr | ₹163 Cr | ₹152 Cr |
Other Long Term Liabilities | ₹55 Cr | ₹45 Cr | ₹57 Cr | ₹41 Cr | ₹11 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹79 Cr | ₹53 Cr | ₹45 Cr | ₹32 Cr | ₹31 Cr |
Total Non-Current Liabilities | ₹2,101 Cr | ₹979 Cr | ₹730 Cr | ₹-79 Cr | ₹-109 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹332 Cr | ₹219 Cr | ₹125 Cr | ₹118 Cr | ₹103 Cr |
Sundry Creditors | ₹332 Cr | ₹219 Cr | ₹125 Cr | ₹118 Cr | ₹103 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹531 Cr | ₹900 Cr | ₹190 Cr | ₹36 Cr | ₹29 Cr |
Bank Overdraft / Short term credit | ₹3.92 Cr | - | ₹15 Cr | ₹9.26 Cr | ₹9.30 Cr |
Advances received from customers | ₹19 Cr | ₹21 Cr | ₹3.34 Cr | ₹3.87 Cr | ₹2.89 Cr |
Interest Accrued But Not Due | ₹96 Cr | ₹10 Cr | ₹2.74 Cr | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | ₹438 Cr | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹412 Cr | ₹432 Cr | ₹169 Cr | ₹23 Cr | ₹17 Cr |
Short Term Borrowings | ₹397 Cr | ₹1,311 Cr | ₹55 Cr | ₹0.01 Cr | ₹0.01 Cr |
Secured ST Loans repayable on Demands | ₹396 Cr | ₹330 Cr | ₹55 Cr | - | - |
Working Capital Loans- Sec | ₹396 Cr | ₹330 Cr | ₹55 Cr | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-396 Cr | ₹652 Cr | ₹-55 Cr | ₹0.01 Cr | ₹0.01 Cr |
Short Term Provisions | ₹230 Cr | ₹179 Cr | ₹151 Cr | ₹130 Cr | ₹104 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹152 Cr | ₹116 Cr | ₹82 Cr | ₹91 Cr | ₹76 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹78 Cr | ₹62 Cr | ₹69 Cr | ₹39 Cr | ₹27 Cr |
Total Current Liabilities | ₹1,490 Cr | ₹2,609 Cr | ₹521 Cr | ₹283 Cr | ₹235 Cr |
Total Liabilities | ₹6,862 Cr | ₹6,810 Cr | ₹3,472 Cr | ₹2,113 Cr | ₹1,703 Cr |
ASSETS | |||||
Gross Block | ₹6,061 Cr | ₹4,773 Cr | ₹2,843 Cr | ₹1,092 Cr | ₹1,006 Cr |
Less: Accumulated Depreciation | ₹754 Cr | ₹454 Cr | ₹275 Cr | ₹174 Cr | ₹152 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹5,306 Cr | ₹4,319 Cr | ₹2,568 Cr | ₹918 Cr | ₹854 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹67 Cr | ₹19 Cr | ₹21 Cr | ₹24 Cr | - |
Non Current Investments | ₹62 Cr | ₹16 Cr | ₹6.69 Cr | ₹421 Cr | ₹244 Cr |
Long Term Investment | ₹62 Cr | ₹16 Cr | ₹6.69 Cr | ₹421 Cr | ₹244 Cr |
Quoted | ₹0.33 Cr | ₹5.33 Cr | ₹0.33 Cr | ₹0.35 Cr | ₹0.36 Cr |
Unquoted | ₹62 Cr | ₹10 Cr | ₹6.36 Cr | ₹420 Cr | ₹243 Cr |
Long Term Loans & Advances | ₹88 Cr | ₹70 Cr | ₹25 Cr | ₹36 Cr | ₹26 Cr |
Other Non Current Assets | ₹7.35 Cr | ₹7.26 Cr | ₹7.37 Cr | - | ₹42 Cr |
Total Non-Current Assets | ₹5,531 Cr | ₹4,431 Cr | ₹2,629 Cr | ₹1,402 Cr | ₹1,167 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹5.00 Cr | - | ₹30 Cr | ₹100 Cr | ₹50 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹5.00 Cr | - | ₹30 Cr | ₹100 Cr | ₹50 Cr |
Inventories | ₹335 Cr | ₹189 Cr | ₹131 Cr | ₹118 Cr | ₹94 Cr |
Raw Materials | ₹127 Cr | ₹65 Cr | ₹45 Cr | ₹39 Cr | ₹17 Cr |
Work-in Progress | ₹7.93 Cr | ₹11 Cr | ₹3.84 Cr | ₹1.98 Cr | ₹2.64 Cr |
Finished Goods | ₹32 Cr | ₹38 Cr | ₹20 Cr | ₹23 Cr | ₹25 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹5.35 Cr | ₹8.05 Cr | ₹0.96 Cr | ₹1.04 Cr | ₹0.29 Cr |
Other Inventory | ₹162 Cr | ₹68 Cr | ₹62 Cr | ₹53 Cr | ₹49 Cr |
Sundry Debtors | ₹459 Cr | ₹422 Cr | ₹293 Cr | ₹161 Cr | ₹140 Cr |
Debtors more than Six months | ₹24 Cr | ₹42 Cr | ₹6.57 Cr | ₹36 Cr | ₹4.91 Cr |
Debtors Others | ₹470 Cr | ₹402 Cr | ₹290 Cr | ₹128 Cr | ₹139 Cr |
Cash and Bank | ₹223 Cr | ₹1,401 Cr | ₹58 Cr | ₹52 Cr | ₹38 Cr |
Cash in hand | ₹0.52 Cr | ₹0.24 Cr | ₹0.03 Cr | ₹0.12 Cr | ₹0.08 Cr |
Balances at Bank | ₹220 Cr | ₹1,393 Cr | ₹58 Cr | ₹42 Cr | ₹33 Cr |
Other cash and bank balances | ₹2.27 Cr | ₹6.97 Cr | - | ₹11 Cr | ₹5.07 Cr |
Other Current Assets | ₹27 Cr | ₹32 Cr | ₹22 Cr | ₹24 Cr | ₹36 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | ₹0.08 Cr | ₹0.06 Cr | ₹1.83 Cr | ₹0.76 Cr |
Prepaid Expenses | ₹20 Cr | ₹26 Cr | ₹17 Cr | ₹21 Cr | ₹7.99 Cr |
Other current_assets | ₹7.24 Cr | ₹6.44 Cr | ₹5.07 Cr | ₹0.77 Cr | ₹27 Cr |
Short Term Loans and Advances | ₹283 Cr | ₹335 Cr | ₹308 Cr | ₹256 Cr | ₹176 Cr |
Advances recoverable in cash or in kind | ₹57 Cr | ₹115 Cr | ₹69 Cr | ₹62 Cr | ₹58 Cr |
Advance income tax and TDS | ₹108 Cr | ₹77 Cr | ₹78 Cr | ₹84 Cr | ₹69 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹117 Cr | ₹143 Cr | ₹161 Cr | ₹110 Cr | ₹50 Cr |
Total Current Assets | ₹1,331 Cr | ₹2,379 Cr | ₹843 Cr | ₹711 Cr | ₹536 Cr |
Net Current Assets (Including Current Investments) | ₹-158 Cr | ₹-230 Cr | ₹321 Cr | ₹428 Cr | ₹300 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹6,862 Cr | ₹6,810 Cr | ₹3,472 Cr | ₹2,113 Cr | ₹1,703 Cr |
Contingent Liabilities | ₹64 Cr | ₹54 Cr | ₹28 Cr | ₹25 Cr | ₹20 Cr |
Total Debt | ₹2,422 Cr | ₹2,735 Cr | ₹830 Cr | ₹45 Cr | ₹0.01 Cr |
Book Value | - | 189.75 | 161.28 | 140.25 | 115.81 |
Adjusted Book Value | 208.83 | 189.79 | 161.28 | 140.25 | 115.81 |
Compare Balance Sheet of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹23,429.8 Cr | -4.5% | -1% | 51.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | -4.5% |
-1% |
51.3% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses